Confirmed Number of Doses* Procured by Purchaser's country economic status

Larger purchases and procurement of approved vaccines mean a smaller piece of the pie for low- and middle-income countries as well as for equity-focused partnerships like COVAX.

*Data does not include domestic supply data for Russia or China, as this information has not been made publicly available. Economic status figures from World Bank EU is included as a high-income region and Latin America as an upper middle income region, given that the regions can be largely represented by the aforementioned income categories.
Source: The Launch and Scale Speedometer is led by the Duke Global Health Innovation Center, with support from the Bill & Melinda Gates Foundation. Data as of Nov. 12, 2021 Embed